Medication Effects on Inflammatory Markers

Introduction to Medication Effects

Medications such as statins and NSAIDs have been shown to affect C-Reactive Protein (CRP) levels, a marker of inflammation, with pravastatin significantly decreasing CRP levels over a 5-year follow-up period, independent of its effect on lowering LDL cholesterol, according to the American Heart Association 1
Aspirin, an NSAID, reduces serum CRP levels, particularly in patients with elevated inflammatory markers, as recommended by the American College of Cardiology 1

The European Society of Cardiology recommends using NSAIDs, such as ibuprofen, as a mainstay therapy for acute pericarditis, where CRP normalization is used to guide treatment duration (Class IIa, Level of Evidence C) 2
The typical dose of ibuprofen for inflammatory conditions is 600 mg every 8 hours, with a recommended decrease of 200-400 mg every 1-2 weeks when tapering 2
Treatment duration with NSAIDs is typically guided by symptoms and CRP normalization, generally 1-2 weeks for uncomplicated cases 2
Monitoring CRP levels is recommended, with baseline measurement before starting therapy, follow-up measurement to assess treatment response, and continuation of treatment until symptoms resolve and CRP normalizes 2

Ibuprofen may antagonize the antiplatelet effects of aspirin, potentially reducing its cardioprotective benefits 3
If ibuprofen must be used with aspirin, it is recommended to take ibuprofen at least 30 minutes after immediate-release aspirin or at least 8 hours before aspirin, as suggested by clinical guidelines 4

The European Society of Cardiology suggests that serum CRP should be considered to guide treatment length and assess response to therapy in inflammatory conditions like pericarditis (Class IIa, Level of Evidence C) 2
The American College of Cardiology and the American Heart Association provide recommendations on the use of medications such as aspirin and statins to reduce inflammation and improve cardiovascular outcomes 1